openPR Logo
Press release

New Director Sales and Business Development for GEA Pharma Systems in Latin America

01-10-2012 04:31 AM CET | Science & Education

Press release from: GEA Pharma Systems

/ PR Agency: The Words Workshop
Zósimo López Moreno

Zósimo López Moreno

GEA Pharma Systems has appointed Zósimo López Moreno as its Director Sales and Business Development for Latin America.

Zósimo will have direct management responsibility for all GEA Pharma Systems’ product lines. These include: Courtoy™ tablet presses; high shear granulation and fluid bed processing from Aeromatic-Fielder™; ConsiGma™ continuous processing and Single Pot processing from Collette™; Lyophil freeze dryers and loading & unloading systems; Buck® high containment and materials handling technology; and fermentation and liquid formulation from Diessel.

Zósimo has been involved in the supply of capital equipment to the global processing industry for most of his career and has qualifications in Mechanical Engineering and an MBA in International Business. For the last 12 years he has worked in the pharmaceutical, cosmetic, dairy, beverage and food industries to devise and implement appropriate technology for the Latin American market.

“I am delighted to have joined this rapidly growing organisation and am looking forward to using the strength of the worldwide GEA Group to help our Latin American customers,” he said. GEA Pharma Systems is already recognised in Latin America for the quality and tradition of its equipment. The organisation is supported in Brazil by STEQ (www.steq.com.br), in Mexico by Rasch (www.rasch.com.mx) and in Argentina by Vanyrelco. “It is this quality and the strength of our local partners that is the key to successfully meeting anticipated customer demands and expectations.”

Frans K.A. Maas, Vice President Sales and Marketing for GEA Pharma Systems is equally pleased with the new appointment. “With the addition of Zósimo Lopez we’re bringing a breadth of market experience to our team,” he said. “We are enforcing our message that GEA Pharma Systems is delivering top-line technologies and integrated systems, at the right price-performance level, to this fast growing market – and we plan on being there for the long run.”

GEA Pharma Systems’ return on performance in Latin America is based on local presence, widespread customer references, in-depth pharmaceutical process knowledge, a competitive manufacturing portfolio of products, all supported by a strong global service network.

The GEA Group has a long tradition of supplying high quality capital equipment for the global processing industry, with over 22,000 employees worldwide. The main factories for pharmaceutical industry are in Switzerland, United Kingdom, Belgium, Germany, Denmark, the USA, India and China.

Where inspiration meets technology

GEA Pharma Systems is part of the GEA Group and a specialist in powder handling machinery for the pharmaceutical sector. Products include: tablet presses, granulation and agglomeration equipment, high containment valves, bulk handling equipment, and freeze drying systems for pharmaceuticals.

All editorial enquiries to:
Steve Jordan
The Words Workshop Ltd
26 Swanwick Lane, Broughton, Milton Keynes, MK10 9LD
Tel: +44 1908 695500
E-mail: steve@thewordsworkshop.co.uk
Web: www.thewordsworkshop.co.uk

All business enquiries to:
Zósimo López Moreno
Sales & Business Development Director – Latin America
Mobile: +52 1 55 45540845
Fax : +52 55 53439923
E-mail: zosimo.lopez@geagroup.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New Director Sales and Business Development for GEA Pharma Systems in Latin America here

News-ID: 206483 • Views:

More Releases from GEA Pharma Systems

Janssen Pharmaceutica teams up with GEA Pharma Systems to investigate continuous …
Janssen Pharmaceutica, part of the worldwide Janssen Pharmaceutica Group, has initiated a global project with the aim of evaluating technical performance and related business benefits of continuous processing technologies for oral solid dosage forms. In this context, ConsiGma™ continuous processing technology from GEA Pharma Systems has been assessed for tablet manufacture. During an in-depth feasibility study at GEA Pharma Systems’ lab, the team from Janssen has been able to
GEA Pharma Systems presents European granulation, drying, tableting and fermenta …
GEA Pharma Systems will be exhibiting at CHINA-PHARM 2012 from 24 to 27 September at the China National Convention Center in Beijing. Exhibits on stand number 3017 will include examples of the company’s range of Aeromatic-Fielder™ and Collette™ granulation and drying plant; MODUL™ tablet presses from Courtoy™; and pharmaceutical fermentation systems from GEA Diessel showing state-of-the-art technology for a bioreactor vessel. On 25 September the company will present a
Combined pharmaceutical freeze drying service proves a success in China for GEA …
It was in November 2010 that GEA Pharma Systems acquired Beijing Sino-German Tianhe Technology in Beijing to create GEA Lyophil (Beijing) Ltd. Since then, the company has quadrupled turnover and enhanced its customer service by blending German quality and Chinese economy to provide a unique combined offering to its pharmaceutical clients. Jinbin Tang, MD, GEA Lyophil (Beijing) Ltd. said that the market had changed in China since the introduction of new
GEA Pharma Systems wins large order for continuous solid dose processing from major US pharmaceutical company
GEA Pharma Systems wins large order for continuous solid dose processing from ma …
GEA Pharma Systems has announced an agreement with a US pharmaceutical company to supply a complete continuous processing line for the production of solid dose drugs. The order is one of the more significant for ConsiGma™ oral solid dosage continuous processing equipment and represents the first phase of a potentially long-term commitment for this customer. Delivery is scheduled for early 2013. The order is to deliver a continuous solid

All 5 Releases